SCHEMBL2573902

SCHEMBL2573902

Cc1cn(-c2cnc3nnn(Cc4cccc5cccnc45)c3n2)cn1

nearest known ligand 0.47

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.47
PSEN2 P49810 1/20 0.47
KCNH2 Q12809 1/20 0.47
APH1B Q8WW43 1/20 0.47
NCSTN Q92542 1/20 0.47
APH1A Q96BI3 1/20 0.47
PSENEN Q9NZ42 1/20 0.47
MET P08581 19/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2569624 0.80 MET (0.73) MET
SCHEMBL2566584 0.74 MET (0.70) MET
SCHEMBL2573970 0.74 MET (0.69) MET
SCHEMBL2572016 0.73 MET (0.68) MET
SCHEMBL2572265 0.73 MET (0.48) MET
SCHEMBL2575215 0.73 MET (0.47) MET
SCHEMBL2569722 0.72 MET (0.61) PSEN1PSEN2KCNH2APH1BNCSTN
SCHEMBL2574066 0.71 MET (0.56) MET
SCHEMBL2572670 0.71 MET (0.56) MET
SCHEMBL2013882 0.69 MET (0.72) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2018383-B1 TRIAZOLOPYRAZINE DERIVATIVES USEFUL AS ANTI-CANCER AGENTS PFIZER PROD INC (US) 2011-11-09 EP claimed